SUGUME
Cancer Risk Test Series
SUGUME Test Kit Product Lineup
SUGUME is a series of rapid and easy-to-use test kits developed with the concept of “immediate and accessible testing anytime, anywhere.”
These kits cover the seven major lifestyle-related diseases and more, providing results in just 5 to 15 minutes.
Designed for busy, working-age individuals, SUGUME offers a new option for health management.
These convenient at-home test kits support the early detection of lifestyle-related diseases and infectious illnesses, helping users lead healthier and more fulfilling lives.
We are happy to help making healthcare more affordable and accessible by partnering up with SUGUME!
This test kit measures hemoglobin and transferrin, which are know to be present in colon cancer and colon polyps.
Colon cancer is one of the most common cancers, and if it is detected early, the 5-year survival rate is said to be over 94%, highlighting the importance of early detection.
This test kit detect CA19-9, a tumor marker for gastrointestinal diseases such as pancreatic cancer.
In the early stages, there are almost no specific symptoms so it’s hard to notice but more evolved it is, the more difficult it is to be treated.
This test kit detects free sulhydryl groups and human papillomavirus in urine.
If detected early, the five-year survival rate is said to be over 92%, emphasising the importance of early detection.
This Test kit can detect breast cancer with the tumor marker CA15-3.
If it is discovered early, there is a high chance of recovery, but as it progresses, it may become necessary to have breast removal, and there is an increased risk of cancer cells metastasizing.
This Test kit detects the tumor marker PSA, or prostate-specific antigen from a small amount of blood.
Prostate cancer is increasing sharply since late half of 20th Century and it is important to get tested regularly.
This stomach cancer risk test detects H. PYLORI, a bacterium linked to gastritis, ulcers, and other digestive issues.
Testing is recommended for those taking stomach medications or with a family history of H. PYLORIi infections. A simple one-time test for better digestive health.
This Test kit uses a small amount of blood to detect a tumor marker called AFP (alpha-fetoprotein), which occurs in malignant diseases such as hepatocellular carcinoma.
Since there are almost no specific symptoms in the early stages, it is considered to be one of the most difficult cancer to detect early.
Liver Cirrhosis risk test kit
This rapid HCV test kit detects antibodies to HCV in whole blood, serum, or plasma.
It uses colloidal gold conjugates and recombinant HCV proteins to selectively identify HCV antibodies.
This rapid Hepatitis B Risk Test Kit detects the presence of HBsAg (Hepatitis B surface antigen) in whole blood, serum, or plasma.
It uses a combination of monoclonal and polyclonal antibodies for selective and reliable detection.
Infectious disease risk test series
This test detects antibodies to both HIV-1 and HIV-2 in blood, plasma, or serum, offering a reliable method for HIV screening.
Despite differences in biological features, serological activity, and genome sequences, HIV-1 and HIV-2 exhibit strong cross-reactivity, making this test effective for diagnosis and blood product screening.
This rapid Candida Test Kit detects the presence of Candida, a type of yeast that can cause various health issues when it multiplies excessively.
This rapid test kit is designed to detect gonorrhea and chlamydia from swab samples taken from the urethra or cervix, providing a convenient and effective screening method.
This kit detects Treponema pallidum antibodies (IgG and IgM), providing results in just 5 minutes with a high accuracy rate of 99.8%.
It empowers individuals to take proactive steps in monitoring their sexual health.
This kit detects Trichomonas vaginalis antigens, delivering results in approximately 15 minutes with a 95% accuracy rate.
This provides a convenient and private method to assess their risk of Trichomonas infection at home.